Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.7807
-0.0344 (-4.22%)
May 14, 2025, 10:06 AM - Market open

Sutro Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
106.23190.369.2747.2530.41206.15
Upgrade
Short-Term Investments
142.74126.59306.35287.11167.52161.99
Upgrade
Cash & Short-Term Investments
248.97316.9375.62334.36197.94368.14
Upgrade
Cash Growth
-20.51%-15.63%12.34%68.92%-46.23%212.34%
Upgrade
Receivables
13.568.6236.087.1212.455.56
Upgrade
Prepaid Expenses
24.8817.89.8511.678.124.49
Upgrade
Total Current Assets
287.41343.31421.54353.15218.52378.18
Upgrade
Property, Plant & Equipment
33.0835.8744.7651.0651.5912.94
Upgrade
Long-Term Investments
----68.78-
Upgrade
Other Long-Term Assets
0.948.034.442.732.532.99
Upgrade
Total Assets
321.43387.21470.74406.94341.41394.11
Upgrade
Accounts Payable
8.1810.489.444.86.015.54
Upgrade
Accrued Expenses
33.9540.1334.124.8317.078.82
Upgrade
Current Portion of Long-Term Debt
--4.0612.59.38-
Upgrade
Current Portion of Leases
7.777.486.424.591.04-
Upgrade
Current Income Taxes Payable
-0.0215.17---
Upgrade
Current Unearned Revenue
68.9869.7820.6716.765.514.6
Upgrade
Other Current Liabilities
14.174.013.93.082.750.63
Upgrade
Total Current Liabilities
133.05131.8993.7566.5541.7429.6
Upgrade
Long-Term Debt
---3.7715.7424.55
Upgrade
Long-Term Leases
13.6315.6723.1529.5731.22-
Upgrade
Long-Term Unearned Revenue
198.87193.35202.4989.89-6.1
Upgrade
Other Long-Term Liabilities
1.691.691.690.120.151.82
Upgrade
Total Liabilities
347.24342.61321.09189.988.8462.06
Upgrade
Common Stock
0.080.080.060.060.050.05
Upgrade
Additional Paid-In Capital
836.95831.35708.98670.22586.24559.75
Upgrade
Retained Earnings
-862.84-786.87-559.41-452.62-333.41-227.87
Upgrade
Comprehensive Income & Other
-0.010.040.02-0.62-0.310.13
Upgrade
Total Common Equity
-25.8144.6149.65217.05252.56332.05
Upgrade
Shareholders' Equity
-25.8144.6149.65217.05252.56332.05
Upgrade
Total Liabilities & Equity
321.43387.21470.74406.94341.41394.11
Upgrade
Total Debt
21.423.1533.6450.4357.3724.55
Upgrade
Net Cash (Debt)
227.58293.74341.98283.93209.34343.59
Upgrade
Net Cash Growth
-20.19%-14.11%20.45%35.63%-39.07%177.99%
Upgrade
Net Cash Per Share
2.773.825.685.604.5410.55
Upgrade
Filing Date Shares Outstanding
84.4683.7862.4460.1646.3845.89
Upgrade
Total Common Shares Outstanding
84.3582.5361.0157.546.3345.75
Upgrade
Working Capital
154.36211.42327.8286.61176.78348.59
Upgrade
Book Value Per Share
-0.310.542.453.775.457.26
Upgrade
Tangible Book Value
-25.8144.6149.65217.05252.56332.05
Upgrade
Tangible Book Value Per Share
-0.310.542.453.775.457.26
Upgrade
Machinery
-42.124037.6331.8232.79
Upgrade
Construction In Progress
-0.50.51.690.511.08
Upgrade
Leasehold Improvements
-24.2123.6123.2223.6515.9
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q